Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Can Cai

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Structure (London, England : 1993)|August 30, 2025
Capsid structure of phage SPO1 reveals novel minor capsid proteins and insights into capsid stabilizationXinyue Zhao, Aohan Wang, Yueting Wang, et al.
Atherosclerosis|July 18, 2018
Characterization of LncRNA expression profile and identification of novel LncRNA biomarkers to diagnose coronary artery diseaseLin Li, Laiyuan Wang, Hongfan Li, et al.
Oncotarget|May 13, 2017
Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease developmentKun He, Xiwen Zhu, Yan Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2023
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 studyJürgen Wolf, Edward B Garon, Harry J M Groen, et al.
Medicine and Science in Sports and Exercise|September 13, 2023
Genetic Predisposition, Sedentary Behavior, and Incident Coronary Artery Disease: A Prospective Chinese Cohort StudyChunyu Hu, Keyong Huang, Can Cai, et al.
BMC Cancer|October 25, 2024
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLCArmando Santoro, Garrido Pilar, Daniel S W Tan, et al.
Aging|September 7, 2021
m<sup>6</sup>A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progressionDong Xiao, Ting-Xiao Fang, Ye Lei, et al.
Blood|October 13, 2023
Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasisWoosuk S Hur, Tomohiro Kawano, Jean Marie N Mwiza, et al.
Journal of Geriatric Cardiology : JGC|September 16, 2021
Associations of tea consumption with blood pressure progression and hypertension incidenceXiao-Ge Niu, Can Cai, Fang-Chao Liu, et al.
The Lancet. Oncology|February 22, 2014
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trialRobert J Motzer, Camillo Porta, Nicholas J Vogelzang, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Structure (London, England : 1993)|August 30, 2025
Capsid structure of phage SPO1 reveals novel minor capsid proteins and insights into capsid stabilizationXinyue Zhao, Aohan Wang, Yueting Wang, et al.
Atherosclerosis|July 18, 2018
Characterization of LncRNA expression profile and identification of novel LncRNA biomarkers to diagnose coronary artery diseaseLin Li, Laiyuan Wang, Hongfan Li, et al.
Oncotarget|May 13, 2017
Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease developmentKun He, Xiwen Zhu, Yan Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2023
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 studyJürgen Wolf, Edward B Garon, Harry J M Groen, et al.
Medicine and Science in Sports and Exercise|September 13, 2023
Genetic Predisposition, Sedentary Behavior, and Incident Coronary Artery Disease: A Prospective Chinese Cohort StudyChunyu Hu, Keyong Huang, Can Cai, et al.
BMC Cancer|October 25, 2024
Spartalizumab in combination with platinum-doublet chemotherapy with or without canakinumab in patients with PD-L1-unselected, metastatic NSCLCArmando Santoro, Garrido Pilar, Daniel S W Tan, et al.
Aging|September 7, 2021
m<sup>6</sup>A demethylase ALKBH5 suppression contributes to esophageal squamous cell carcinoma progressionDong Xiao, Ting-Xiao Fang, Ye Lei, et al.
Blood|October 13, 2023
Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasisWoosuk S Hur, Tomohiro Kawano, Jean Marie N Mwiza, et al.
Journal of Geriatric Cardiology : JGC|September 16, 2021
Associations of tea consumption with blood pressure progression and hypertension incidenceXiao-Ge Niu, Can Cai, Fang-Chao Liu, et al.
The Lancet. Oncology|February 22, 2014
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trialRobert J Motzer, Camillo Porta, Nicholas J Vogelzang, et al.
Pageof 8